ENTITY
111 Inc

111 Inc (YI US)

120
Analysis
Information TechnologyChina
111, Inc. operates as a digital and mobile healthcare platform. The Company offers pharmacy distribution, medical consultancy, e-prescription, and other services. 111 serves patients in China.
more
Refresh
bearishMeituan
03 Sep 2018 06:48

Last Week in GER Research: Meituan-Dianping, Nio, Gangfeng Lithium, Pinduoduo and 111 Inc

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a more palatable...

Logo
333 Views
Share
bearish111 Inc
30 Aug 2018 18:58

111 Inc IPO Valuation: Pricing Does Not Adequately Reflect the Risks

111 Inc (YI US) announced its IPO price range of $14-16 per ADS. At the mid-point of the IPO price range, 111 will raise net proceeds of...

Logo
542 Views
Share
27 Aug 2018 06:05

Last Week in GER Research: Haidilao, Xiaomi, Ping An, 111, Qutoutiao, Nio and Tesla

Below is a recap of the key IPO and fundamental research produced by the Global Equity Research team. This week we highlight a differentiated...

Logo
351 Views
Share
bearish111 Inc
20 Aug 2018 05:05

111 Inc IPO Preview: A New Business Papers over the Cracks

111 Inc (1647603D CH) runs an online retail drugstore (1 Drugstore) and healthcare platform in China. 1 Drugstore is the largest direct sales...

Logo
689 Views
Share
18 Aug 2018 11:48

ECM Coverage Weekly Update (18 August 2018)

Aequitas Research puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs. This week, the market was...

Share
x